Luigi Iannone
Overview
Explore the profile of Luigi Iannone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pasquini B, Seravalli V, Vannuccini S, La Torre F, Geppetti P, Iannone L, et al.
Reprod Biomed Online
. 2023 May;
47(1):71-76.
PMID: 37202318
Research Question: Women with endometriosis are frequently affected by headache. How many of these have a clear diagnosis of migraine? Are the different forms of migraine related to the phenotypes...
2.
Amoruso G, Nistico S, Iannone L, Russo E, Rago G, Patruno C, et al.
Healthcare (Basel)
. 2021 Jun;
9(5).
PMID: 34066917
Background: Psoriasis is a chronic dermatological condition characterized by lesions on extensor surfaces, hands, feet, and genital areas. Chronic renal failure is often associated with metabolic syndrome and inflammatory conditions,...
3.
Barbieri M, Cicala G, Cutroneo P, Gerratana E, Palleria C, De Sarro C, et al.
J Clin Med
. 2020 Apr;
9(4).
PMID: 32344563
Post-marketing surveillance activities are essential to detect the risk/benefit profile of biologic disease-modifying antirheumatic drugs (bDMARDs) in inflammatory arthritis. The aim of this study was to evaluate adverse events (AEs)...
4.
Pharmacology of new and developing intravenous therapies for the management of seizures and epilepsy
Morano A, Iannone L, Palleria C, Fanella M, Giallonardo A, De Sarro G, et al.
Expert Opin Pharmacother
. 2018 Nov;
20(1):25-39.
PMID: 30403892
Introduction: Antiepileptic drugs (AEDs) are administered orally for chronic use. Parenteral formulations might be necessary when the oral route is not feasible (e.g. an impairment of consciousness, trauma, dysphagia, gastrointestinal...
5.
Palleria C, Iannone L, Leporini C, Citraro R, Manti A, Caminiti M, et al.
PLoS One
. 2018 Oct;
13(10):e0205134.
PMID: 30356301
Introduction: Post-marketing surveillance activities (namely pharmacovigilance) are crucial to favor the early detection of unexpected adverse events (AEs) and/or serious adverse reactions (SAEs). Indeed, spontaneous reporting of AEs has been...
6.
Mikroyannidi E, Stevens R, Iannone L, Rector A
J Biomed Semantics
. 2012 Dec;
3(1):8.
PMID: 23244503
Motivation: In this paper we demonstrate the usage of RIO; a framework for detecting syntactic regularities using cluster analysis of the entities in the signature of an ontology. Quality assurance...
7.
Jupp S, Horridge M, Iannone L, Klein J, Owen S, Schanstra J, et al.
BMC Bioinformatics
. 2012 Mar;
13 Suppl 1:S5.
PMID: 22373396
Background: Ontologies are being developed for the life sciences to standardise the way we describe and interpret the wealth of data currently being generated. As more ontology based applications begin...
8.
Rector A, Iannone L
J Biomed Inform
. 2011 Oct;
45(2):199-209.
PMID: 22024315
A study of the use of common qualifiers in SNOMED CT definitions and the resulting classification was undertaken using combined lexical and semantic techniques. The accuracy of SNOMED authors in...